Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
5.01
-0.08 (-1.67%)
Aug 6, 2026, 10:37 AM EDT - Market open
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 533 employees as of December 31, 2025. The number of employees increased by 165 or 44.84% compared to the previous year.
Employees
533
Change (1Y)
165
Growth (1Y)
44.84%
Revenue / Employee
$404,730
Profits / Employee
-$515,672
Market Cap
300.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 533 | 165 | 44.84% |
| Dec 31, 2024 | 368 | 165 | 81.28% |
| Dec 31, 2023 | 203 | -87 | -30.00% |
| Dec 31, 2022 | 290 | 12 | 4.32% |
| Dec 31, 2021 | 278 | -14 | -4.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fate Therapeutics | 161 |
| Foghorn Therapeutics | 106 |
| Neumora Therapeutics | 92 |
| OmniAb | 89 |
| SAB Biotherapeutics | 86 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 55 |
| Anavex Life Sciences | 34 |
VNDA News
- 18 hours ago - Vanda Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 18 hours ago - Vanda Pharmaceuticals Earnings release: Q2 2026 - Filings
- 18 hours ago - Vanda Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 18 hours ago - Vanda Pharmaceuticals reports Q2 EPS ($1.04) vs. (46c) last year - TheFly
- 18 hours ago - Vanda Pharmaceuticals sees FY26 revenue $240M-$290M, consensus $262.1M - TheFly
- 18 hours ago - Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results - PRNewsWire
- 7 days ago - Vanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026 - PRNewsWire
- 20 days ago - Vanda announces EMA positive opinion for orphan drug designation of Imsidolimab - TheFly